The dependence of EBV-specific CD8+ T-cells on the SLAMF4–SAP pathway to target infected B-cells together with the narrow B-cells tropism of EBV may represent two of the underlining principles for the strong susceptibility of XLP patients to this virus. Here, SH2D1A is linked to X-linked lymphoproliferative disease.